Animal healthcare market

Europe Animal Healthcare Market, By Drug Type (Anti-Infective Agents, Anti-Inflammatory & Analgesic Agents, Parasiticides, Vaccines, Hormones & Substitutes, and Others), By Animal Type (Livestock (Bovine, Porcine, Poultry, and Other), Companion (Canine, Feline, Equine), By Indication (Infectious Diseases, Pain Management, Auto-immune Disease, and Others)

  • Apr 2024
  • CMI550
  • 195 Pages
  • Excel & Pdf
  • Pharmaceutical
N/A

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Drug Type
      • Market Snapshot, By Animal Type
      • Market Snapshot, By Indication
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Impact Analysis
    • Market Trends
    • Recent Developments
    • Regulatory Scenario
    • Technological Advancements
    • Acquisitions and Partnerships Scenario
    • Funding and Investments
    • PEST Analysis
    • Porter’s Analysis
  4. Europe Animal Healthcare Market - Impact of Coronavirus (COVID-19) Pandemic
    • Overall Impact
    • Government Initiatives
    • COVID-19 impact on the market
  5. Europe Animal Healthcare Market, By Drug Type, 2019 – 2031, (USD Mn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Anti-Infective Agents
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
    • Anti-Inflammatory & Analgesic Agents
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
    • Parasiticides
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
    • Vaccines
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
    • Hormones & Substitutes
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
  6. Europe Animal Healthcare Market, By Animal Type, 2019 – 2031, (USD Mn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Livestock 
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
        • Bovine
        • Porcine
        • Poultry
        • Other
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
    • Companion 
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn) 
        • Canine
        • Feline
        • Equine
  7. Europe Animal Healthcare Market, By Indication, 2019 – 2031, (USD Mn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Infectious Diseases
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
    • Pain Management
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
    • Auto-immune Disease
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
  8. Competitive Landscape
    • Company Profiles
      • Merck & Co., Inc.*
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Virbac
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Dechra Pharmaceuticals
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Vetoquinol S.A.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Zoetis Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Ceva Santé Animale
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Bayer AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Elanco
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Evonik Industries AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Archer Daniels Midland Company
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Cargill, Incorporated
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • SeQuent Scientific Ltd.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Hester Biosciences
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Bioiberica S.A.U
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
  9. Analyst View
    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  10. References and Research Methodology
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 21 market data tables and 18 figures on “Animal Healthcare Market” -Europe forecast to 2031

Detailed Segmentation-

  • By Drug Type:
    • Anti-Infective Agents
    • Anti-Inflammatory & Analgesic Agents
    • Parasiticides
    • Vaccines
    • Hormones & Substitutes
    • Others
  • By Animal Type:
    • Livestock 
      • Bovine
      • Porcine
      • Poultry
      • Other
    • Companion 
      • Canine
      • Feline
      • Equine
  • By Indication:
    • Infectious Diseases
    • Pain Management
    • Auto-immune Disease
    • Others
- Frequently Asked Questions -

What will be the CAGR of the Europe animal healthcare market?

The CAGR of the Europe animal healthcare market is projected to be 5.1% from 2024 to 2031.

What are the major factors driving the Europe animal healthcare market growth?

Rising pet ownership and increasing mutual recognition agreement among regulatory authorities are the major factors driving the growth of the Europe animal healthcare  market.

What are the key factors hampering growth of the Europe animal healthcare market?

Rising pet care costs and growing pet insurance costs are the major factors hampering the growth of the Europe animal healthcare market.

Which is the leading Drug Type in the Europe animal healthcare market?

In terms of Drug Type, anti-infective agents is estimated to dominate the market revenue share in 2024.

Which are the major players operating in the Europe animal healthcare market?

Merck & Co., Inc., Virbac, Dechra Pharmaceuticals, Vetoquinol S.A., Zoetis Inc., Ceva Santé Animale, Bayer AG, Elanco, Evonik Industries AG, Archer Daniels Midland Company, Cargill, Incorporated, SeQuent Scientific Ltd., Hester Biosciences, and Bioiberica S.A.U are the major players.
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.